Molecular Devices Announces the Release of AquaMax(R) Series of Microplate Washers
30 Juli 2007 - 2:00PM
PR Newswire (US)
SUNNYVALE, CA, July 30 /PRNewswire-FirstCall/ -- Molecular Devices,
a division of MDS Analytical Technologies and a leader in
innovative solutions for drug discovery and life sciences research,
announced today the launch of the AquaMax(R) 2000 and AquaMax(R)
4000 series of microplate washers. The unique modular design of
this new washer platform allows researchers to configure the system
for their current microplate format and applications, and provides
an affordable upgrade path when assay requirements change. The
system's 96- and 384-well wash heads are interchangeable to extend
the capabilities of the system on a single instrument platform. The
AquaMax system washes the wells of microplate-based biological
assays, an integral component of life science research. Primary
applications for this instrument include ELISA, immunoassays, and
cytotoxicity assays, and many cell-based assays used in
high-throughput screening during the drug discovery process. The
system washes all wells in the microplate simultaneously, resulting
in very fast microplate processing unlike conventional washers that
sequentially fill wells by strip or quadrant dispensing. On-board,
touch-screen programming gives researchers a high degree of control
over microplate processing parameters resulting in fast and
efficient plate washing. The system's highly efficient washing
capability minimizes background interference and maximizes assay
sensitivity. A comprehensive cleaning routine prevents clogged
dispense head and probes, the primary cause of microplate washer
failure. Unlike competitive instruments, AquaMax is completely
self-contained and does not require external pumps or computers.
"The AquaMax washer series represents the latest advancements in
liquid handling products. With the ability to use both 96- and
384-well wash heads on the base platform, customers can switch
easily and quickly between formats, increasing their range of
applications using one instrument," said Andy Boorn, President of
MDS Analytical Technologies. "With the system's increased
reliability, speed and flexibility, we expect customers will see
significant time and cost savings over conventional wash systems."
About MDS Inc. MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life
sciences company that provides market-leading products and services
that our customers need for the development of drugs and diagnosis
and treatment of disease. We are a leading global provider of
pharmaceutical contract research, medical isotopes for molecular
imaging, radiotherapeutics, and analytical instruments. MDS has
more than 6,200 highly skilled people in 28 countries. Find out
more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. About MDS Analytical Technologies MDS Analytical
Technologies is a newly established MDS Inc. business unit and is a
world-class organization comprised of two main lines of business.
The Sciex product portfolio offers proven market leadership in mass
spectrometry through its joint ventures with two of the world's
leading analytical instrumentation and life sciences companies,
Applied Biosystems, a business of the Applera Corporation and
PerkinElmer Inc. The Molecular Devices product portfolio is the
gold standard in high-performance bioanalytical measurement systems
that accelerate and improve drug discovery and other life sciences
research. Find out more at http://www.moleculardevices.com/ or
http://www.mdssciex.com/. DATASOURCE: MDS Analytical Technologies
CONTACT: Media: Cheri Salazar, Director, Marketing Communications,
Molecular Devices, now part of MDS Analytical Technologies, (408)
548-6316, ; Investors: Sharon Mathers, Senior Vice-President,
Investor Relations and External Communications, MDS Inc., (416)
675-6777 x 34721,
Copyright